Korot, Edward http://orcid.org/0000-0002-5687-1564
Guan, Zeyu http://orcid.org/0000-0003-3050-4210
Ferraz, Daniel
Wagner, Siegfried K.
Zhang, Gongyu http://orcid.org/0000-0003-4760-359X
Liu, Xiaoxuan http://orcid.org/0000-0002-1286-0038
Faes, Livia
Pontikos, Nikolas http://orcid.org/0000-0003-1782-4711
Finlayson, Samuel G.
Khalid, Hagar
Moraes, Gabriella
Balaskas, Konstantinos http://orcid.org/0000-0002-7690-6277
Denniston, Alastair K. http://orcid.org/0000-0001-7849-0087
Keane, Pearse A. http://orcid.org/0000-0002-9239-745X
Article History
Received: 1 June 2020
Accepted: 26 January 2021
First Online: 1 March 2021
Competing interests
: E.K. has been a consultant for Google Health, the parent company of which (Google) has created one of the platforms evaluated in this study. P.A.K. has been a consultant for the artificial intelligence company, DeepMind, the parent company of which (Google) has created one of the platforms evaluated in this study. P.A.K. has received speaker fees from Heidelberg Engineering, Topcon, Carl Zeiss Meditec, Haag-Streit, Allergan, Novartis and Bayer. He has served on advisory boards for Novartis and Bayer and has been an external consultant for DeepMind and Optos. All other authors declare no competing interests.